Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular Nanocarriers
Author:
Affiliation:
1. Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, Massachusetts 02138, United States
Funder
National Center for Advancing Translational Sciences
National Heart, Lung, and Blood Institute
Publisher
American Chemical Society (ACS)
Subject
General Physics and Astronomy,General Engineering,General Materials Science
Link
https://pubs.acs.org/doi/pdf/10.1021/acsnano.1c11374
Reference68 articles.
1. Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions
2. Capture of Stealth Nanoparticles by the Body’s Defences
3. Analysis of nanoparticle delivery to tumours
4. Liposomal drug delivery systems: From concept to clinical applications
5. Design of polymeric nanoparticles for biomedical delivery applications
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recent advances with erythrocytes as therapeutics carriers;International Journal of Pharmaceutics;2024-11
2. Engineering cells or cellular outer membranes as multifaceted vehicles for reinforcing nanomedicine-based pulmonary disease treatment;Nano Today;2024-10
3. Toward the Integration of Machine Learning and Molecular Modeling for Designing Drug Delivery Nanocarriers;Advanced Materials;2024-09-10
4. Dual-targeting galactose-functionalized hyaluronic acid modified lipid nanoparticles delivering silybin for alleviating alcoholic liver injury;International Journal of Pharmaceutics;2024-09
5. Marginated Neutrophils in the Lungs Effectively Compete for Nanoparticles Targeted to the Endothelium, Serving as a Part of the Reticuloendothelial System;ACS Nano;2024-08-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3